Cogent Biosciences, Inc. Stock Analysis & AI Score
Cogent Biosciences, Inc. (COGT) has an ST Score of 54.3 (B-), driven by its Valuation (A-) and held back by its Profitability (C). Analysts rate it Buy with a $51.75 price target (+64.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Cogent Biosciences, Inc. (COGT) has an ST Score of 54.3 (B-), driven by its Valuation (A-) and held back by its Profitability (C). Analysts rate it Buy with a $51.75 price target (+64.7% upside).
- Strongest
- ValuationA-
- Weakest
- ProfitabilityC
All factor grades
- ValuationA-
- ForecastB+
- Financial StrengthB
- GrowthB
- MomentumC+
- ProfitabilityC
- Piotroski2/9
Contact
COGT stock: frequently asked questions
What is COGT's ST Score?
Cogent Biosciences, Inc. (COGT) has an ST Score of 54.3 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is COGT a buy, hold, or sell?
Analysts rate COGT a Buy, with a price target of $51.75 (+64.7% vs the current price). Our ST Score grades it B- (54.3/100). The ST Score is a data-driven signal, not a recommendation.
What are COGT's factor grades?
Valuation A-, Profitability C, Financial Strength B, Momentum C+, Growth B, Forecast B+.
What is COGT's valuation grade?
Cogent Biosciences, Inc. (COGT) earns a valuation grade of A-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is COGT's growth grade?
Cogent Biosciences, Inc. (COGT) earns a growth grade of B, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is COGT's profitability grade?
Cogent Biosciences, Inc. (COGT) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is COGT's financial strength grade?
Cogent Biosciences, Inc. (COGT) earns a financial strength grade of B, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for COGT?
The average analyst price target for Cogent Biosciences, Inc. (COGT) is $51.75 from 12 analysts, which is +64.7% versus the recent price of $31.43.
What is COGT's Piotroski score?
Cogent Biosciences, Inc. (COGT) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.